RNA as the catalyst for drug screening - Reporter ribozymes that allow monitoring of protein-nucleic acid and protein-protein interactions facilitate rapid identification of inhibitors for use in drug discovery.
Journal Article
Overview
publication date
has subject area
Biochemical Phenomena - Amino Acid Sequence
Biochemical Phenomena - Base Sequence
Biochemical Phenomena - Protein Binding
Biochemical Phenomena - Structure-Activity Relationship
Carrier Proteins - Gene Products, rev
Catalysis
DNA - DNA, Single-Stranded
Enzymes - RNA, Catalytic
Genetic Structures - Base Sequence
Genetic Structures - DNA, Single-Stranded
Humans
Investigative Techniques - Drug Evaluation, Preclinical
Investigative Techniques - Drug Evaluation, Preclinical
Metabolism - Protein Binding
Molecular Conformation - DNA, Single-Stranded
Molecular Sequence Data
Molecular Sequence Data - Amino Acid Sequence
Molecular Sequence Data - Base Sequence
Nucleoproteins - Gene Products, rev
Pharmacological Phenomena - Structure-Activity Relationship
Protein Interaction Mapping
Proteins
RNA, Untranslated - RNA, Catalytic
Viral Regulatory and Accessory Proteins - Gene Products, rev
has restriction
Date in CU Experts
September 9, 2013 10:29 AM
Full Author List
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue
